To Demonstrate the Relative Bioequivalency Study of Dosage Forms of Clemastine 2.68 mg Tablets
Clinical trial NCT00913549 · COMPLETED
Trial details
- NCT number
- NCT00913549
- Sponsor
- Sandoz
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 1989-12-01
- Primary completion
- 1990-01-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.